Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Gambogic acid-loaded transferrin-modified liposomes enhancing potent ferroptosis in breast cancer
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 10 April 2026

Gambogic acid-loaded transferrin-modified liposomes enhancing potent ferroptosis in breast cancer

  • Wenqing Rong1 na1,
  • Minquan Zhang2 na1,
  • Siqi Yang3 na1,
  • Kaiwen Wang1,
  • Xiaoping Yang1,
  • Guolei Zhang1,
  • Zhe Li2,3,
  • Yue Ding2,3,
  • Tong Zhang2,3,
  • Yun Gai1 &
  • …
  • Jinshuai Lan1,2 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biochemistry
  • Biotechnology
  • Cancer
  • Drug discovery
  • Oncology

Abstract

Breast cancer (BC), the most common cancer in women, is closely related to ferroptosis, which is an iron-dependent form of cell death. Gambogic acid (GA), the main active ingredient extracted from the dry resin secreted by Garcinia cambogia, can effectively induce ferroptosis in tumor cells. However, its application is limited by poor water solubility, short half-life, and vascular irritation. Moreover, the sensitivity of cells to ferroptosis is positively correlated with the concentration of intracellular iron ions, which based on transferrin (Tf)-Tf receptor (TfR) pathway. Increasing intracellular iron ions within tumor cells may enhance GA-induced ferroptosis. Based on the high expression of TfR in tumor cells, Tf can be both a tumor-target modification and an Fe3+ carrier. Therefore, GA-loaded Tf-modified liposomes (GA@Tf-Lip) with pH-responsive properties were developed. GA@Tf-Lip increased the intracellular iron ion content of MCF-7 cells, promoted the Fenton reaction to increase the level of ROS, downregulated the GSH content, and accelerated lipid peroxide accumulation. The distribution of the formulation by in vivo imaging experiments showed that the prepared GA@Tf-Lip had a higher drug accumulation at tumor sites and exhibited a good antitumor effect by promoting ferroptosis. Overall, GA@Tf-Lip exerted a good anti-BC effect, which is expected to provide a new strategy for the treatment of BC and the clinical transformation of GA.

Data availability

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Feng, Y. et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. GENES Dis. 5, 77–106 (2018).

    Google Scholar 

  2. Liao, L. Inequality in breast cancer: Global statistics from 2022 to 2050. Breast 79, 103851 (2025).

    Google Scholar 

  3. Arnold, M. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66, 15–23 (2022).

    Google Scholar 

  4. Zhai, J., Wu, Y., Ma, F., Kaklamani, V. & Xu, B. Advances in medical treatment of breast cancer in 2022. Cancer Innov. 2, 1–17 (2023).

    Google Scholar 

  5. Ge, A. et al. Broadening horizons: The multifaceted role of ferroptosis in breast cancer. Front. Immunol. 15, 1455741 (2024).

    Google Scholar 

  6. Zhang, M. Q. et al. Ferroptosis meets biomimetic nano-systems: A novel strategy for targeted cancer therapy. Cell Biomater. 1, 100023 (2025).

    Google Scholar 

  7. Zheng, J. et al. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis. 12, 698 (2021).

    Google Scholar 

  8. Pan, X. et al. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis. Oncol. Lett. 17, 3001–3008 (2019).

    Google Scholar 

  9. Sui, X. et al. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front. Pharmacol. 9, 1371 (2018).

    Google Scholar 

  10. Liang, X. et al. Metal-organic framework-based photodynamic combined immunotherapy against the distant development of triple-negative breast cancer. Biomater. Res. 27, 120 (2023).

    Google Scholar 

  11. Rashidzadeh, H. et al. Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor. Int. J. Biol. Macromol. 233, 123273 (2023).

    Google Scholar 

  12. Xia, C. et al. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche. ACTA Biomater. 158, 708–724 (2023).

    Google Scholar 

  13. Zhang, Y. et al. Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma. Biomaterials 278, 121163 (2021).

    Google Scholar 

  14. Zhang, Y. et al. Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interfaces 12, 43408–43421 (2020).

    Google Scholar 

  15. Chen, H. & Wen, J. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway. Eur. J. Pharmacol. 921, 174860 (2022).

    Google Scholar 

  16. Hatami, E., Jaggi, M., Chauhan, S. C. & Yallapu, M. M. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochim. Biophys. Acta (BBA) 1874, 188381 (2020).

    Google Scholar 

  17. Jing, Y. et al. Development of a manganese complex hyaluronic acid hydrogel encapsulating stimuli-responsive Gambogic acid nanoparticles for targeted Intratumoral delivery. Int. J. Biol. Macromol. 270, 132348 (2024).

    Google Scholar 

  18. Miller, L. D. et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 71, 6728–6737 (2011).

    Google Scholar 

  19. de Oliveira, M. C. et al. pH-sensitive liposomes as a carrier for oligonucleotides: A physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophys. Chem. 87, 127–137 (2000).

    Google Scholar 

  20. Lan, J. et al. Shuttle-like Fe(III)-gambogic acid nanoassemblies: Disrupting intracellular redox balance and enhancing tumor penetration to amplify ferroptosis therapy of large tumors. Adv. Compos. Hybrid. Mater. 8, 338 (2025).

    Google Scholar 

  21. Ma, Z. et al. Enhanced anticancer efficacy of dual drug-loaded self-assembled nanostructured lipid carriers mediated by pH-responsive folic acid and human-derived cell penetrating peptide dNP2. Pharmaceutics 13, 600 (2021).

    Google Scholar 

  22. Lan, J. et al. Unlocking the anticancer activity of gambogic acid: A shift towards ferroptosis via a GSH/Trx dual antioxidant system. Free Radic. Biol. Med. 218, 26–40 (2024).

    Google Scholar 

  23. Alic, L., Binder, C. J. & Papac-Milicevic, N. The OSE complotype and its clinical potential. Front. Immunol. 13, 1010893 (2022).

    Google Scholar 

  24. Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317–331 (2014).

    Google Scholar 

  25. Chen, Y., Zhang, P., Chen, W. & Chen, G. Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway. Immunol. Lett. 225, 9–15 (2020).

    Google Scholar 

  26. Chen, L., Hambright, W. S., Na, R. & Ran, Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J. Biol. Chem. 290, 28097–28106 (2015).

    Google Scholar 

  27. Nijhawan, H. P., Shyamsundar, P., Prabhakar, B. & Yadav, K. S. PEGylated pH-responsive liposomes for enhancing the intracellular uptake and cytotoxicity of paclitaxel in MCF-7 breast cancer cells. AAPS PharmSciTech 25, 216 (2024).

    Google Scholar 

  28. Uggeri, J. et al. Calcein-AM is a detector of intracellular oxidative activity. Histochem. Cell Biol. 122, 499–505 (2004).

    Google Scholar 

  29. Krapoth, T. C. et al. Wanted: Dead or alive cells with propidium iodide staining in liver tissue. Int. J. Mol. Sci. 25, 13521 (2024).

    Google Scholar 

  30. Guan, Z. et al. Self-enhanced targeted nanomedicines based on iron starvation acclimation for tumor-specific therapy. Chem. Eng. J. 495, 153371 (2024).

    Google Scholar 

  31. Grubwieser, P. et al. Quantification of macrophage cellular ferrous iron (Fe2+) content using a highly specific fluorescent probe in a plate reader. Bio Protoc. 14, e4929 (2024).

    Google Scholar 

  32. Pedrera, L. et al. Ferroptosis triggers mitochondrial fragmentation via Drp1 activation. Cell Death Dis. 16, 40 (2025).

    Google Scholar 

Download references

Acknowledgements

This work was financially supported by Programs of the National Natural Science Foundation of China (grant number 82274066); National Key Research and Development Program of China (grant 2022YFC3501705); Shanghai Leading Talent (grant number 2019100); Program of Shanghai Academic/Technology Research Leader (grant 22XD1423000); “Shuguang Program” supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission (grant number 20SG43); Project from Shanghai Committee of Science and Technology (grant number 22S21901200 and 21010504200); Youth Talent Program from the Shanghai Municipal Health Commission (Grant 2022YQ030); Natural Science Foundation of Shanghai (grant number 21ZR1460800 and 22ZR1459000); Excellent Young medical talents Training Program of Pudong New Area Health Commission (grant number PWRq2024-42); National Traditional Chinese Medicine Inheritance and Innovation Development Pilot Zone Construction Project in Pudong New Area (grant number PDZY-2025-0722); Scientific Research Fund of Wu Jie-ping Medical Foundation (grant number 320.6750.2023-19-53).

Author information

Author notes
  1. These authors contributed equally: Wenqing Rong, Minquan Zhang and Siqi Yang.

Authors and Affiliations

  1. Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China

    Wenqing Rong, Kaiwen Wang, Xiaoping Yang, Guolei Zhang, Yun Gai & Jinshuai Lan

  2. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China

    Minquan Zhang, Zhe Li, Yue Ding, Tong Zhang & Jinshuai Lan

  3. State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China

    Siqi Yang, Zhe Li, Yue Ding & Tong Zhang

Authors
  1. Wenqing Rong
    View author publications

    Search author on:PubMed Google Scholar

  2. Minquan Zhang
    View author publications

    Search author on:PubMed Google Scholar

  3. Siqi Yang
    View author publications

    Search author on:PubMed Google Scholar

  4. Kaiwen Wang
    View author publications

    Search author on:PubMed Google Scholar

  5. Xiaoping Yang
    View author publications

    Search author on:PubMed Google Scholar

  6. Guolei Zhang
    View author publications

    Search author on:PubMed Google Scholar

  7. Zhe Li
    View author publications

    Search author on:PubMed Google Scholar

  8. Yue Ding
    View author publications

    Search author on:PubMed Google Scholar

  9. Tong Zhang
    View author publications

    Search author on:PubMed Google Scholar

  10. Yun Gai
    View author publications

    Search author on:PubMed Google Scholar

  11. Jinshuai Lan
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Wenqing Rong: Writing—original draft, Writing—review and editing, Formal Analysis, Data Curation, Investigation. Minquan Zhang: Writing—original draft, Writing—review and editing, Formal Analysis, Data Curation, Investigation. Siqi Yang: Writing—original draft, Writing-review and editing, Formal Analysis, Data Curation, Investigation. Kaiwen Wang: Writing—review and editing, Conceptualization, Investigation, Formal analysis. Xiaoping Yang: Writing—review and editing, Investigation, Formal analysis. Guolei Zhang: Writing—review and editing, Visualization, Investigation. Zhe Li: Writing—review and editing, Conceptualization, Methodology, Visualization. Yue Ding: Writing—review and editing, Resources, Funding acquisition, Methodology. Tong Zhang: Writing—review and editing, Project administration, Supervision, Resources, Methodology, Funding acquisition, Conceptualization. Yun Gai: Writing—review and editing, Project administration, Supervision, Resources, Methodology, Funding acquisition, Conceptualization. Jinshuai Lan: Writing—review and editing, Supervision, Funding acquisition, Resources, Project administration, Methodology, Conceptualization.

Corresponding authors

Correspondence to Tong Zhang, Yun Gai or Jinshuai Lan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and informed consent

All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Shanghai University of Traditional Chinese Medicine (PZSHUTCM2309080007, PZSHUTCM2309110010). All experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of Shanghai University of Traditional Chinese Medicine. At the end of the experiments, the mice were euthanized by intraperitoneal injection of excessive 1.25% tribromoethanol (20 μL/g), the rabbits were euthanized via intraperitoneal injection injection of excessive soidum pentobarbital (100 mg/kg). Authors confirmed that all animal experiments were performed in accordance with ARRIVE guidelines.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Supplementary Information. (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rong, W., Zhang, M., Yang, S. et al. Gambogic acid-loaded transferrin-modified liposomes enhancing potent ferroptosis in breast cancer. Sci Rep (2026). https://doi.org/10.1038/s41598-026-47971-z

Download citation

  • Received: 03 December 2025

  • Accepted: 06 April 2026

  • Published: 10 April 2026

  • DOI: https://doi.org/10.1038/s41598-026-47971-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Gambogic acid
  • Transferrin
  • Ferroptosis
  • Target drug delivery
  • Breast cancer
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer